Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, announced a global out-license agreement with AstraZeneca...
Blueprint Medicines Corporation, a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, announced that, effective on April 1, 2022,...
Evergreen Nephrology is announcing a joint venture with Colorado Kidney Care, a single specialty nephrology practice caring for patients in the greater Denver Metropolitan...
Covestro, a leading polymer company, is proud to announce its collaboration with PharmaJet, a leading biotech company in needle-free injection technology. PharmaJet's Needle-free Injection...
SaltMED, a medical device company focused on innovative medical aesthetic technology, is pleased to announce the manufacturing agreement with Jabil (NYSE: JBL), to become...
